Literature DB >> 19368900

Serotonin modulation of cerebral glucose metabolism in depressed older adults.

Gwenn S Smith1, Elisse Kramer, Carol Hermann, Yilong Ma, Vijay Dhawan, Thomas Chaly, David Eidelberg.   

Abstract

BACKGROUND: Monoamine dysfunction, particularly of the serotonin system, has been the dominant hypothesis guiding research and treatment development in affective disorders. The majority of research has been performed in midlife depressed adults. The importance of understanding the neurobiology of depression in older adults is underscored by increased rates of mortality and completed suicide and an increased risk of Alzheimer's dementia. To evaluate the dynamic response of the serotonin system, the acute effects of citalopram infusion on cerebral glucose metabolism was measured in depressed older adults and control subjects. The hypothesis was tested that smaller decreases in metabolism would be observed in cortical and limbic regions in depressed older adults relative to control subjects.
METHODS: Sixteen depressed older adults and 13 control subjects underwent two resting positron emission tomography (PET) studies with the radiotracer [18F]-2-deoxy-2-fluoro-D-glucose after placebo and citalopram infusions.
RESULTS: In control subjects compared with depressed older adults, greater citalopram-induced decreases in cerebral metabolism were observed in the right anterior cingulate, middle temporal (bilaterally), left precuneus, and left parahippocampal gyri. Greater decreases in the depressed older adults than control subjects were observed in left superior and left middle frontal gyri and increases in left inferior parietal lobule, left cuneus, left thalamus, and right putamen.
CONCLUSIONS: In depressed older adults relative to control subjects, the cerebral metabolic response to citalopram is blunted in cortico-cortical and cortico-limbic pathways and increased in the left hemisphere (greater decrease interiorly and increases posteriorly). These findings suggest both blunted and compensatory cerebral metabolic responses to citalopram in depressed older adults.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19368900      PMCID: PMC2706292          DOI: 10.1016/j.biopsych.2009.02.012

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  55 in total

1.  Effect of 5-HT1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus.

Authors:  R Invernizzi; C Velasco; M Bramante; A Longo; R Samanin
Journal:  Neuropharmacology       Date:  1997 Apr-May       Impact factor: 5.250

2.  The assessment of anxiety states by rating.

Authors:  M HAMILTON
Journal:  Br J Med Psychol       Date:  1959

3.  A rating scale for depression.

Authors:  M HAMILTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-02       Impact factor: 10.154

Review 4.  Selective serotonin reuptake inhibitors and neuroendocrine function.

Authors:  D K Raap; L D Van de Kar
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

5.  Prefrontal and striatal activation during sequence learning in geriatric depression.

Authors:  Howard J Aizenstein; Meryl A Butters; Jennifer L Figurski; V Andrew Stenger; Charles F Reynolds; Cameron S Carter
Journal:  Biol Psychiatry       Date:  2005-08-15       Impact factor: 13.382

6.  Cytology and functionally correlated circuits of human posterior cingulate areas.

Authors:  Brent A Vogt; Leslie Vogt; Steven Laureys
Journal:  Neuroimage       Date:  2005-09-06       Impact factor: 6.556

7.  Cerebral glucose metabolic response to combined total sleep deprivation and antidepressant treatment in geriatric depression.

Authors:  G S Smith; C F Reynolds; B Pollock; S Derbyshire; E Nofzinger; M A Dew; P R Houck; D Milko; C C Meltzer; D J Kupfer
Journal:  Am J Psychiatry       Date:  1999-05       Impact factor: 18.112

8.  Regional brain responses to serotonin in major depressive disorder.

Authors:  Amy D Anderson; Maria A Oquendo; Ramin V Parsey; Matthew S Milak; Carl Campbell; J John Mann
Journal:  J Affect Disord       Date:  2004-11-01       Impact factor: 4.839

9.  Effects of age at onset of first lifetime episode of recurrent major depression on treatment response and illness course in elderly patients.

Authors:  C F Reynolds; M A Dew; E Frank; A E Begley; M D Miller; C Cornes; S Mazumdar; J M Perel; D J Kupfer
Journal:  Am J Psychiatry       Date:  1998-06       Impact factor: 18.112

10.  Treatment of 70(+)-year-olds with recurrent major depression. Excellent short-term but brittle long-term response.

Authors:  C F Reynolds; E Frank; M A Dew; P R Houck; M Miller; S Mazumdar; J M Perel; D J Kupfer
Journal:  Am J Geriatr Psychiatry       Date:  1999       Impact factor: 4.105

View more
  22 in total

1.  Stability in brain glucose metabolism following brown adipose tissue inactivation in chinese adults.

Authors:  Q Miao; X L Zhao; Q Y Zhang; Z Y Zhang; Y H Guan; H Y Ye; S Zhang; M F Zeng; C T Zuo; Y M Li
Journal:  AJNR Am J Neuroradiol       Date:  2012-05-10       Impact factor: 3.825

Review 2.  Positron emission tomography molecular imaging in late-life depression.

Authors:  Kentaro Hirao; Gwenn S Smith
Journal:  J Geriatr Psychiatry Neurol       Date:  2014-01-05       Impact factor: 2.680

3.  Brain serotonergic circuitries.

Authors:  Yves Charnay; Lucienne Léger
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

4.  Neuropsychiatric symptoms in Alzheimer's disease.

Authors:  Constantine G Lyketsos; Maria C Carrillo; J Michael Ryan; Ara S Khachaturian; Paula Trzepacz; Joan Amatniek; Jesse Cedarbaum; Robert Brashear; David S Miller
Journal:  Alzheimers Dement       Date:  2011-09       Impact factor: 21.566

5.  Functional connectivity patterns of the subgenual anterior cingulate cortex in first-episode refractory major depressive disorder.

Authors:  Bochao Cheng; Yajing Meng; Yan Zuo; Yi Guo; Xiuli Wang; Song Wang; Ran Zhang; Wei Deng; Yingkun Guo; Gang Ning
Journal:  Brain Imaging Behav       Date:  2021-01-12       Impact factor: 3.978

6.  Depressive symptoms accelerate cognitive decline in amyloid-positive MCI patients.

Authors:  Matthias Brendel; Oliver Pogarell; Guoming Xiong; Andreas Delker; Peter Bartenstein; Axel Rominger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-01-29       Impact factor: 9.236

7.  Neuron density and serotonin receptor binding in prefrontal cortex in suicide.

Authors:  Mark D Underwood; Suham A Kassir; Mihran J Bakalian; Hanga Galfalvy; J John Mann; Victoria Arango
Journal:  Int J Neuropsychopharmacol       Date:  2011-05-09       Impact factor: 5.176

8.  Molecular imaging of serotonin degeneration in mild cognitive impairment.

Authors:  Gwenn S Smith; Frederick S Barrett; Jin Hui Joo; Najlla Nassery; Alena Savonenko; Devin J Sodums; Christopher M Marano; Cynthia A Munro; Jason Brandt; Michael A Kraut; Yun Zhou; Dean F Wong; Clifford I Workman
Journal:  Neurobiol Dis       Date:  2017-05-13       Impact factor: 5.996

9.  The relationship between fasting serum glucose and cerebral glucose metabolism in late-life depression and normal aging.

Authors:  Christopher M Marano; Clifford I Workman; Christopher H Lyman; Elisse Kramer; Carol R Hermann; Yilong Ma; Vijay Dhawan; Thomas Chaly; David Eidelberg; Gwenn S Smith
Journal:  Psychiatry Res       Date:  2014-02-01       Impact factor: 3.222

10.  Metabolic imaging of bilateral anterior capsulotomy in refractory obsessive compulsive disorder: an FDG PET study.

Authors:  ChuanTao Zuo; Yilong Ma; BoMin Sun; Shichun Peng; HuiWei Zhang; David Eidelberg; YiHui Guan
Journal:  J Cereb Blood Flow Metab       Date:  2013-02-27       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.